{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:41:03Z","timestamp":1770882063389,"version":"3.50.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI106705"],"award-info":[{"award-number":["P01 AI106705"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS083687"],"award-info":[{"award-number":["R01 NS083687"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI077774"],"award-info":[{"award-number":["P01 AI077774"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Charles S. Britton Fund","award":["R01 NS052319"],"award-info":[{"award-number":["R01 NS052319"]}]},{"name":"The Charles S. Britton Fund","award":["R01 NS088604"],"award-info":[{"award-number":["R01 NS088604"]}]},{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","award":["UR8\/CCU515004"],"award-info":[{"award-number":["UR8\/CCU515004"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","award":["K99\/R00 AG068359"],"award-info":[{"award-number":["K99\/R00 AG068359"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021080","name":"CJD Foundation","doi-asserted-by":"publisher","award":["P30 AG010133"],"award-info":[{"award-number":["P30 AG010133"]}],"id":[{"id":"10.13039\/100021080","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer\u2019s Disease Research and Education"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>It is increasingly evident that the association of glycans with the prion protein (PrP), a major post-translational modification, significantly impacts the pathogenesis of prion diseases. A recent bioassay study has provided evidence that the presence of PrP glycans decreases spongiform degeneration and disease-related PrP (PrPD) deposition in a murine model. We challenged (PRNPN181Q\/197Q) transgenic (Tg) mice expressing glycan-free human PrP (TgGlyc\u2212), with isolates from sporadic Creutzfeldt\u2013Jakob disease subtype MM2 (sCJDMM2), sporadic fatal insomnia and familial fatal insomnia, three human prion diseases that are distinct but share histotypic and PrPD features. TgGlyc\u2212 mice accurately replicated the basic histotypic features associated with the three diseases but the transmission was characterized by high attack rates, shortened incubation periods and a greatly increased severity of the histopathology, including the presence of up to 40 times higher quantities of PrPD that formed prominent deposits. Although the engineered protease-resistant PrPD shared at least some features of the secondary structure and the presence of the anchorless PrPD variant with the wild-type PrPD, it exhibited different density gradient profiles of the PrPD aggregates and a higher stability index. The severity of the histopathological features including PrP deposition appeared to be related to the incubation period duration. These findings are clearly consistent with the protective role of the PrP glycans but also emphasize the complexity of the conformational changes that impact PrPD following glycan knockout. Future studies will determine whether these features apply broadly to other human prion diseases or are PrPD-type dependent.<\/jats:p>","DOI":"10.1093\/brain\/awad399","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T01:27:10Z","timestamp":1700875630000},"page":"1539-1552","source":"Crossref","is-referenced-by-count":6,"title":["Efficient transmission of human prion diseases to a glycan-free prion protein-expressing host"],"prefix":"10.1093","volume":"147","author":[{"given":"Laura","family":"Cracco","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University, School of Medicine , Indianapolis, IN 46202 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Cali","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"},{"name":"National Prion Disease Pathology Surveillance Center, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabail","family":"Aslam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Notari","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhong","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"},{"name":"National Prion Disease Pathology Surveillance Center, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"},{"name":"Department of Neurology, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy L","family":"Newell","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University, School of Medicine , Indianapolis, IN 46202 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardino","family":"Ghetti","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University, School of Medicine , Indianapolis, IN 46202 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian S","family":"Appleby","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"},{"name":"National Prion Disease Pathology Surveillance Center, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"},{"name":"Department of Neurology, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"},{"name":"Department of Psychiatry, Case Western Reserve University , Cleveland, OH 44106 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Gambetti","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University, School of Medicine , Cleveland, OH 44106 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"2024040418432414700_awad399-B1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-444-63945-5.00002-7","article-title":"The cellular and pathologic prion protein","volume":"153","author":"Gill","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"2024040418432414700_awad399-B2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2000-2104","article-title":"The Thr183Ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein","volume":"2","author":"Capellari","year":"2000","journal-title":"J Alzheimers Dis"},{"key":"2024040418432414700_awad399-B3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI131564","article-title":"Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease","volume":"130","author":"Sevillano","year":"2020","journal-title":"J Clin Invest"},{"key":"2024040418432414700_awad399-B4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","article-title":"Sporadic and familial CJD: Classification and characterisation","volume":"66","author":"Gambetti","year":"2003","journal-title":"Br Med Bull"},{"key":"2024040418432414700_awad399-B5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/glycob\/1.1.101","article-title":"Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites","volume":"1","author":"Rogers","year":"1990","journal-title":"Glycobiology"},{"key":"2024040418432414700_awad399-B6","doi-asserted-by":"crossref","first-page":"21479","DOI":"10.1074\/jbc.272.34.21479","article-title":"Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells","volume":"272","author":"Lehmann","year":"1997","journal-title":"J Biol Chem"},{"key":"2024040418432414700_awad399-B7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0896-6273(00)80424-9","article-title":"Selective neuronal targeting in prion disease","volume":"19","author":"DeArmond","year":"1997","journal-title":"Neuron"},{"issue":"Pt 10","key":"2024040418432414700_awad399-B8","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1099\/0022-1317-81-10-2555","article-title":"Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains","volume":"81","author":"Korth","year":"2000","journal-title":"J Gen Virol"},{"key":"2024040418432414700_awad399-B9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9440(10)64572-5","article-title":"Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain","volume":"157","author":"Capellari","year":"2000","journal-title":"Am J Pathol"},{"key":"2024040418432414700_awad399-B10","doi-asserted-by":"crossref","first-page":"53306","DOI":"10.1074\/jbc.M410796200","article-title":"Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections","volume":"279","author":"Neuendorf","year":"2004","journal-title":"J Biol Chem"},{"key":"2024040418432414700_awad399-B11","doi-asserted-by":"crossref","first-page":"42909","DOI":"10.1074\/jbc.M509557200","article-title":"Altered glycosylated PrP proteins can have different neuronal trafficking in brain but do not acquire scrapie-like properties","volume":"280","author":"Cancellotti","year":"2005","journal-title":"J Biol Chem"},{"key":"2024040418432414700_awad399-B12","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1371\/journal.pbio.0060100","article-title":"Host PrP glycosylation: A major factor determining the outcome of prion infection","volume":"6","author":"Tuzi","year":"2008","journal-title":"PLoS Biol"},{"key":"2024040418432414700_awad399-B13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/emboj.2013.6","article-title":"Post-translational changes to PrP alter transmissible spongiform encephalopathy strain properties","volume":"32","author":"Cancellotti","year":"2013","journal-title":"EMBO J"},{"key":"2024040418432414700_awad399-B14","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1128\/JVI.02296-14","article-title":"The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species","volume":"89","author":"Wiseman","year":"2015","journal-title":"J Virol"},{"key":"2024040418432414700_awad399-B15","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/s41374-019-0282-1","article-title":"Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification","volume":"99","author":"Camacho","year":"2019","journal-title":"Lab Invest"},{"key":"2024040418432414700_awad399-B16","doi-asserted-by":"crossref","first-page":"10420","DOI":"10.1074\/jbc.RA120.012796","article-title":"Incomplete glycosylation during prion infection unmasks a prion protein epitope that facilitates prion detection and strain discrimination","volume":"295","author":"Kang","year":"2020","journal-title":"J Biol Chem"},{"key":"2024040418432414700_awad399-B17","doi-asserted-by":"crossref","first-page":"e1009123","DOI":"10.1371\/journal.ppat.1009123","article-title":"Short and sweet: How glycans impact prion conversion, cofactor interactions, and cross-species transmission","volume":"17","author":"Aguilar-Calvo","year":"2021","journal-title":"PLoS Pathog"},{"key":"2024040418432414700_awad399-B18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","article-title":"Sporadic human prion diseases: Molecular insights and diagnosis","volume":"11","author":"Puoti","year":"2012","journal-title":"Lancet Neurol"},{"key":"2024040418432414700_awad399-B19","doi-asserted-by":"crossref","first-page":"38280","DOI":"10.1038\/srep38280","article-title":"Novel strain properties distinguishing sporadic prion diseases sharing prion protein genotype and prion type","volume":"7","author":"Cracco","year":"2017","journal-title":"Sci Rep"},{"key":"2024040418432414700_awad399-B20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-3-031-20565-1_18","volume-title":"Prions and diseases","author":"Gambetti","year":"2023"},{"key":"2024040418432414700_awad399-B21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-3-031-20565-1_20","volume-title":"Prions and Diseases","author":"Wang","year":"2023"},{"key":"2024040418432414700_awad399-B22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-444-63945-5.00004-0","article-title":"Experimental models of human prion diseases and prion strains","volume":"153","author":"Diack","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"2024040418432414700_awad399-B23","doi-asserted-by":"crossref","first-page":"10168","DOI":"10.1073\/pnas.97.18.10168","article-title":"Genetic influence on the structural variations of the abnormal prion protein","volume":"97","author":"Parchi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024040418432414700_awad399-B24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-444-63945-5.00009-X","article-title":"Sporadic Creutzfeldt-Jakob disease","volume":"153","author":"Zerr","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"2024040418432414700_awad399-B25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-444-63945-5.00010-6","article-title":"Variably protease-sensitive prionopathy","volume":"153","author":"Notari","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"2024040418432414700_awad399-B26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-444-63945-5.00013-1","article-title":"Genetic Creutzfeldt-Jakob disease","volume":"153","author":"Ladogana","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"2024040418432414700_awad399-B27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/B978-0-444-63945-5.00015-5","article-title":"Fatal familial insomnia and sporadic fatal insomnia","volume":"153","author":"Cracco","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"2024040418432414700_awad399-B28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-444-63945-5.00014-3","article-title":"Dominantly inherited prion protein cerebral amyloidoses\u2014A modern view of Gerstmann-Straussler-Scheinker","volume":"153","author":"Ghetti","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"2024040418432414700_awad399-B29","doi-asserted-by":"crossref","first-page":"29846","DOI":"10.1074\/jbc.M113.500108","article-title":"Co-existence of distinct prion types enables conformational evolution of human PrPSc by competitive selection","volume":"288","author":"Haldiman","year":"2013","journal-title":"J Biol Chem"},{"key":"2024040418432414700_awad399-B30","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1523\/JNEUROSCI.2467-05.2005","article-title":"Chronic wasting disease of elk: Transmissibility to humans examined by transgenic mouse models","volume":"25","author":"Kong","year":"2005","journal-title":"J Neurosci"},{"key":"2024040418432414700_awad399-B31","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3201\/eid2012.140548","article-title":"Transmission characteristics of variably protease-sensitive prionopathy","volume":"20","author":"Notari","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2024040418432414700_awad399-B32","first-page":"589","article-title":"Glycans modulate the transmissibility of PrPSc and the sCJDMM2 and sFI phenotypes","volume":"73","author":"Cracco","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024040418432414700_awad399-B33","first-page":"3","article-title":"Transmissibility of human prion diseases","volume":"8","author":"Gambetti","year":"2014","journal-title":"Prion"},{"key":"2024040418432414700_awad399-B34","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1128\/jvi.61.12.3688-3693.1987","article-title":"Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins","volume":"61","author":"Kascsak","year":"1987","journal-title":"J Virol"},{"key":"2024040418432414700_awad399-B35","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41598-020-58446-0","article-title":"Co-existence of PrP(D) types 1 and 2 in sporadic Creutzfeldt-Jakob disease of the VV subgroup: Phenotypic and prion protein characteristics","volume":"10","author":"Cali","year":"2020","journal-title":"Sci Rep"},{"key":"2024040418432414700_awad399-B36","doi-asserted-by":"crossref","first-page":"30557","DOI":"10.1074\/jbc.M801877200","article-title":"Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease","volume":"283","author":"Notari","year":"2008","journal-title":"J Biol Chem"},{"key":"2024040418432414700_awad399-B37","doi-asserted-by":"crossref","first-page":"e12723","DOI":"10.1371\/journal.pone.0012723","article-title":"A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc","volume":"5","author":"Pirisinu","year":"2010","journal-title":"PLoS One"},{"key":"2024040418432414700_awad399-B38","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1128\/JVI.02387-09","article-title":"Experimental verification of a traceback phenomenon in prion infection","volume":"84","author":"Kobayashi","year":"2010","journal-title":"J Virol"},{"key":"2024040418432414700_awad399-B39","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1128\/jvi.66.4.2096-2101.1992","article-title":"Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent","volume":"66","author":"Bessen","year":"1992","journal-title":"J Virol"},{"key":"2024040418432414700_awad399-B40","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1128\/jvi.68.12.7859-7868.1994","article-title":"Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy","volume":"68","author":"Bessen","year":"1994","journal-title":"J Virol"},{"issue":"Pt 9","key":"2024040418432414700_awad399-B41","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/brain\/awl224","article-title":"Classification of sporadic Creutzfeldt-Jakob disease revisited","volume":"129","author":"Cali","year":"2006","journal-title":"Brain"},{"key":"2024040418432414700_awad399-B42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-0173(01)00042-X","article-title":"Microglia and the pathogenesis of spongiform encephalopathies","volume":"35","author":"Rezaie","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"key":"2024040418432414700_awad399-B43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.410380107","article-title":"Regional distribution of protease-resistant prion protein in fatal familial insomnia","volume":"38","author":"Parchi","year":"1995","journal-title":"Ann Neurol"},{"key":"2024040418432414700_awad399-B44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199202133260704","article-title":"Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene","volume":"326","author":"Medori","year":"1992","journal-title":"N Engl J Med"},{"key":"2024040418432414700_awad399-B45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1750-3639.1998.tb00176.x","article-title":"Molecular pathology of fatal familial insomnia","volume":"8","author":"Parchi","year":"1998","journal-title":"Brain Pathol"},{"key":"2024040418432414700_awad399-B46","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1172\/JCI134842","article-title":"Underglycosylated prion protein modulates plaque formation in the brain","volume":"130","author":"Bartz","year":"2020","journal-title":"J Clin Invest"},{"issue":"Pt 3","key":"2024040418432414700_awad399-B47","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/brain\/awl003","article-title":"Pre-symptomatic diagnosis in fatal familial insomnia: Serial neurophysiological and 18FDG-PET studies","volume":"129","author":"Cortelli","year":"2006","journal-title":"Brain"},{"key":"2024040418432414700_awad399-B48","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1073\/pnas.2627989100","article-title":"Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene","volume":"100","author":"Korth","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 10","key":"2024040418432414700_awad399-B49","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/brain\/awp196","article-title":"Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: Its effect on the phenotype and prion-type characteristics","volume":"132","author":"Cali","year":"2009","journal-title":"Brain"},{"key":"2024040418432414700_awad399-B50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00441-022-03665-2","article-title":"Prion strains: Shining new light on old concepts","volume":"392","author":"Block","year":"2023","journal-title":"Cell Tissue Res"},{"key":"2024040418432414700_awad399-B51","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"2024040418432414700_awad399-B52","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1038\/ncomms5347","article-title":"Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked","volume":"5","author":"Sandberg","year":"2014","journal-title":"Nat Commun"},{"key":"2024040418432414700_awad399-B53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00441-022-03683-0","article-title":"Mechanisms of prion-induced toxicity","volume":"392","author":"Mercer","year":"2023","journal-title":"Cell Tissue Res"},{"key":"2024040418432414700_awad399-B54","doi-asserted-by":"crossref","first-page":"23815","DOI":"10.1073\/pnas.2007406117","article-title":"Highly infectious prions are not directly neurotoxic","volume":"117","author":"Benilova","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024040418432414700_awad399-B55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00441-022-03676-z","article-title":"Prion strains viewed through the lens of cryo-EM","volume":"392","author":"Manka","year":"2023","journal-title":"Cell Tissue Res"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awad399\/56976044\/awad399.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/4\/1539\/57163121\/awad399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/4\/1539\/57163121\/awad399.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T18:44:26Z","timestamp":1712256266000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/147\/4\/1539\/7448842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,24]]},"published-print":{"date-parts":[[2024,4,4]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awad399","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2023,11,24]]}}}